Fidelity Investments’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,797
| Closed | -$403K | – | 5690 |
|
|
2022
Q3 | $403K | Sell |
7,797
-10,671,158
| -100% | -$552M | ﹤0.01% | 2843 |
|
|
2022
Q2 | $265M | Buy |
10,678,955
+48,951
| +0.5% | +$1.21M | 0.03% | 606 |
|
|
2022
Q1 | $266M | Buy |
10,630,004
+125,285
| +1% | +$3.14M | 0.02% | 669 |
|
|
2021
Q4 | $382M | Buy |
10,504,719
+19,194
| +0.2% | +$699K | 0.03% | 546 |
|
|
2021
Q3 | $179M | Buy |
10,485,525
+23,090
| +0.2% | +$395K | 0.01% | 854 |
|
|
2021
Q2 | $140M | Buy |
10,462,435
+20,445
| +0.2% | +$274K | 0.01% | 977 |
|
|
2021
Q1 | $535M | Buy |
10,441,990
+60,728
| +0.6% | +$3.11M | 0.05% | 413 |
|
|
2020
Q4 | $643M | Buy |
10,381,262
+47,389
| +0.5% | +$2.93M | 0.06% | 328 |
|
|
2020
Q3 | $566M | Buy |
10,333,873
+167,974
| +2% | +$9.2M | 0.06% | 302 |
|
|
2020
Q2 | $585M | Buy |
10,165,899
+919,214
| +10% | +$52.9M | 0.06% | 272 |
|
|
2020
Q1 | $372M | Buy |
9,246,685
+506,400
| +6% | +$20.3M | 0.05% | 324 |
|
|
2019
Q4 | $346M | Buy |
8,740,285
+2,909,389
| +50% | +$115M | 0.04% | 428 |
|
|
2019
Q3 | $39.5M | Buy |
5,830,896
+167,700
| +3% | +$1.14M | ﹤0.01% | 1284 |
|
|
2019
Q2 | $52.7M | Sell |
5,663,196
-111,236
| -2% | -$1.03M | 0.01% | 1191 |
|
|
2019
Q1 | $80.2M | Buy |
5,774,432
+5,130,127
| +796% | +$71.3M | 0.01% | 994 |
|
|
2018
Q4 | $7.03M | Buy |
+644,305
| New | +$7.03M | ﹤0.01% | 1925 |
|
|
2015
Q1 | – | Sell |
-399,200
| Closed | -$2.73M | – | 2812 |
|
|
2014
Q4 | $2.73M | Buy |
+399,200
| New | +$2.73M | ﹤0.01% | 2372 |
|
|
2013
Q4 | – | Sell |
-350,000
| Closed | -$1.95M | – | 2707 |
|
|
2013
Q3 | $1.95M | Buy |
350,000
+100,000
| +40% | +$556K | ﹤0.01% | 2354 |
|
|
2013
Q2 | $3.54M | Buy |
+250,000
| New | +$3.54M | ﹤0.01% | 2217 |
|